Globus Medical Inc - Class A
Research Globus Medical Inc - Class A (GMED) on Bullrun: valuation model: 10.2% undervalued, market cap USD 10.24B, P/E 19.5. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGMED
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signal10.2% undervalued
- Market capUSD 10.24B
- P/E19.5
- Financial periodQ2 2026
- RevenueUSD 789.61M
- Net incomeUSD 151.57M
- Free cash flowUSD 176.57M
- Gross margin69.4%
Valuation Snapshot
Bullrun's latest valuation model marks Globus Medical Inc - Class A as 10.2% undervalued; latest market cap is USD 10.24B; P/E is 19.5.
Peer valuation comparison
Latest P/E is 19.49x versus a Healthcare sector median of 24.6x (20.8% below).
Latest P/E is 19.49x versus a United States median of 23.85x (18.3% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 2.94B | USD 537.87M | USD 588.77M | 67.4% | 3.92 | USD 526.16M | USD 118.66M | USD 4.57B |
| FY2024 | USD 2.52B | USD 102.98M | USD 405.21M | 58.9% | 0.75 | USD 784.44M | USD 537.19M | USD 4.18B |
| FY2023 | USD 1.57B | USD 122.87M | USD 165.23M | 65.1% | 1.07 | USD 467.29M | USD 520.40M | USD 4.00B |
| FY2022 | USD 1.02B | USD 190.17M | USD 104.42M | 74.2% | 1.85 | USD 150.47M | USD 6.01M | USD 1.85B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 10.24B | 19.5 | n/a | n/a |
| 2025 | 2025-12-31 | USD 11.79B | 22.2 | n/a | n/a |
| 2024 | 2024-12-31 | USD 11.37B | 111.8 | n/a | n/a |
| 2023 | 2023-12-29 | USD 7.34B | 34.4 | n/a | n/a |
| 2022 | 2022-12-30 | USD 7.42B | 49.2 | n/a | n/a |
| 2021 | 2021-12-31 | USD 7.33B | 50.1 | n/a | n/a |
About Globus Medical Inc - Class A
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Globus Medical Inc - Class A overvalued or undervalued?
Bullrun's valuation model currently marks Globus Medical Inc - Class A as 10.2% undervalued.
What is Globus Medical Inc - Class A's market cap?
Globus Medical Inc - Class A's market capitalization is USD 10.24B.
What is Globus Medical Inc - Class A's P/E ratio?
Globus Medical Inc - Class A's price-to-earnings (P/E) ratio is 19.5.
What does Globus Medical Inc - Class A do?
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.